Neogenomics (NEO) EBT Margin Growth (3y) (2013 - 2026)
Neogenomics (NEO) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -211.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 399.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -317.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 4,440.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 135.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -2.00 |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 1,904.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,904.00 |
| Mar 31, 2026 | 1,516.00 |
| Dec 31, 2025 | 1,188.00 |
| Sep 30, 2025 | 1,672.00 |
| Jun 30, 2025 | 754.00 |
| Mar 31, 2025 | 3,010.00 |
| Dec 31, 2024 | 2,578.00 |
| Sep 30, 2024 | 846.00 |
| Jun 30, 2024 | -7,189.00 |
| Mar 31, 2024 | 58.00 |
| Dec 31, 2023 | -1,583.00 |
| Sep 30, 2023 | -1,589.00 |
| Jun 30, 2023 | 251.00 |
| Mar 31, 2023 | -1,902.00 |
| Dec 31, 2022 | -2,068.00 |
| Sep 30, 2022 | -3,410.00 |
| Jun 30, 2022 | -3,494.00 |
| Mar 31, 2022 | -4,072.00 |
| Dec 31, 2021 | -3,699.00 |
| Sep 30, 2021 | -2,210.00 |